Modalis Therapeutics Corporation

Modalis Therapeutics Corporationverified

4883.T

Price:

$63

Market Cap:

$4.85B

Modalis Therapeutics Corporation engages in the research and development of therapeutics to treat patients with serious genetic disorders. It is developing therapies for genetic diseases using its proprietary CRISPR-GNDM technology that enables to control gene expressions through modulating the switch (epigenetics of a specific locus. The company has a. joint research agreement with JCR Pharmaceuticals Co., Ltd. to evaluate the drug delivery technology of the gene therapy to the central nervous system (CNS) assuming CNS diseases as a target. The company was formerly known as EdiGENE Corporation and changed its name to Modalis Therapeutics Corporation in August 2019. Modalis Therapeutics Corp...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2020-08-03

Stock Exchange

JPX

Ticker

4883.T

The Current Ratio as of December 2025 (TTM) for Modalis Therapeutics Corporation (4883.T) is 19.48

According to Modalis Therapeutics Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 19.48. This represents a change of -25.57% compared to the average of 26.18 of the last 4 quarters.

Modalis Therapeutics Corporation (4883.T) Historical Current Ratio (quarterly & annually)

How has 4883.T Current Ratio performed in the past?

The mean historical Current Ratio of Modalis Therapeutics Corporation over the last ten years is 92.58. The current 19.48 Current Ratio has changed 2.00% with respect to the historical average. Over the past ten years (40 quarters), 4883.T's Current Ratio was at its highest in in the September 2024 quarter at 43.88. The Current Ratio was at its lowest in in the March 2024 quarter at 9.79.

Quarterly (TTM)
Annual

Average

92.58

Median

29.43

Minimum

9.88

Maximum

371.64

Modalis Therapeutics Corporation (4883.T) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Modalis Therapeutics Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 212.19%

Maximum Annual Current Ratio = 371.64

Minimum Annual Increase = -74.84%

Minimum Annual Current Ratio = 9.88

Quarterly (TTM)
Annual
YearCurrent RatioChange
202430.83212.19%
20239.88-54.24%
202221.58-23.03%
202128.04-70.02%
202093.51-74.84%

Modalis Therapeutics Corporation (4883.T) Average Current Ratio

How has 4883.T Current Ratio performed in the past?

The current Current Ratio of Modalis Therapeutics Corporation (4883.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

20.76

5-year avg

36.77

10-year avg

92.58

Modalis Therapeutics Corporation (4883.T) Current Ratio vs. Peers

How is 4883.T’s Current Ratio compared to its peers?

Modalis Therapeutics Corporation’s Current Ratio is greater than SymBio Pharmaceuticals Limited (8.71), greater than Nippon Chemiphar Co., Ltd. (2.36), greater than Cyfuse Biomedical K.K. (4.90), greater than WDB coco Co., Ltd. (5.85), greater than PRISM BioLab Co.,LTD (4.64), less than MedRx Co., Ltd (28.01), greater than Solasia Pharma K.K. (3.42), greater than Shigematsu Works Co., Ltd. (1.42), greater than Pharmarise Holdings Corporation (1.10), greater than D. Western Therapeutics Institute, Inc. (12.65),

Build a custom stock screener for Modalis Therapeutics Corporation (4883.T) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Modalis Therapeutics Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Modalis Therapeutics Corporation (4883.T) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Modalis Therapeutics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Modalis Therapeutics Corporation's Current Ratio?

How is the Current Ratio calculated for Modalis Therapeutics Corporation (4883.T)?

What is the highest Current Ratio for Modalis Therapeutics Corporation (4883.T)?

What is the 3-year average Current Ratio for Modalis Therapeutics Corporation (4883.T)?

What is the 5-year average Current Ratio for Modalis Therapeutics Corporation (4883.T)?

How does the current Current Ratio for Modalis Therapeutics Corporation (4883.T) compare to its historical average?